abstract |
The present invention relates to a novel indazole compound of formula ( I ), wherein R 1 is alkyl or cycloalkyl, a compound containing a stereoisomer thereof (formula II ), and a pharmaceutically acceptable salt thereof. The invention also relates to methods of making such compounds and to pharmaceutical compositions comprising such compounds. The compounds of the present invention are useful for the treatment of various disorders associated with 5-hydroxytryptamine 4 (5-HT 4 ) receptor agonists. |